Lupin (NSE:LUPIN) Construction In Progress : ₹5,957 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Lupin Construction In Progress?

Lupin's quarterly construction in progress declined from Sep. 2023 (₹6,757 Mil) to Dec. 2023 (₹0 Mil) but then increased from Dec. 2023 (₹0 Mil) to Mar. 2024 (₹5,957 Mil).

Lupin's annual construction in progress increased from Mar. 2022 (₹8,475 Mil) to Mar. 2023 (₹8,948 Mil) but then declined from Mar. 2023 (₹8,948 Mil) to Mar. 2024 (₹5,957 Mil).

Lupin Construction In Progress Historical Data

The historical data trend for Lupin's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lupin Construction In Progress Chart

Lupin Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Construction In Progress

Get a 7-Day Free Trial

7,581.60

8,515.40

8,474.70

8,948.20

5,956.70

Lupin Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															8,948.20	-	6,756.70	-	5,956.70

Lupin Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Lupin (NSE:LUPIN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lupin Ltd (NSE:LUPIN) » Definitions » Construction In Progress

Traded in Other Exchanges

500257:India

Address

Off. Western Express Highway, 3rd floor, Kalpataru Inspire, Santacruz (East), Mumbai, MH, IND, 400 055

Website

https://www.lupin.com

Lupin Ltd is a specialty and generic drug manufacturing company. The company's global formulations business develops and delivers a wide range of branded and generic formulations across the globe. The operations of the company are limited to one segment, namely pharmaceuticals and related products. The company also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India.

Lupin (NSE:LUPIN) Headlines

No Headlines